VELCADE
- Product NDC
- 63020-049
- 11-digit product format
- 630200049
- Labeler code
- 63020
- Product ID
- 63020-049_3ec85e73-696a-4a2e-aa24-656c6341b23b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bortezomib
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Application
- NDA021602
- Marketing category
- NDA
- Marketing start
- 2003-05-13
- Substance
- BORTEZOMIB
- Active strength
- 3.5 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VELCADE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BORTEZOMIB | 3.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 69G8BD63PP |
| Rxcui | 402243, 402244 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63020-049-01 | VELCADE | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 36 |
| 63020-049-01 | VELCADE | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 36 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| bortezomib | ACTIVE INGREDIENT | 69G8BD63PP | VELCADE (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MILLENNIUM PHARMACEUTICALS, INC.] | 23 | |
| bortezomib | ACTIVE MOIETY | 69G8BD63PP | VELCADE (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MILLENNIUM PHARMACEUTICALS, INC.] | 23 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | VELCADE (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MILLENNIUM PHARMACEUTICALS, INC.] | 23 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63020-049 | VELCADE (BORTEZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 35 | Current NDC, Legacy NDC, 2 package rows | 20221102_1521d321-e724-4ffc-adad-34bf4f44fac7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63020-049-01 | 63020004901 | 1 VIAL in 1 CARTON (63020-049-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2003-05-13 | 0000-00-00 | No | No | Current |